IQVIA Consumer Health and Rx Choice Awards at IQVIA Client Day 2019

Oct 14, 2019

For the 3rd year in a row, IQVIA held the Consumer Health and RX Choice Awards as part of IQVIA Client day. Traditional awarding of Russian OTC market leaders has been expanded: this year, IQVIA also noted leaders in the Rx segment of the Russian Retail Pharmaceutical Market. Six winners were selected based on the data of PharmaTrend – Audit of Drug Sales in pharmacies, which reflects real consumer preferences. More than 150 people who came to IQVIA Client Day joined the celebration to hear the announcement of the winners in the following categories:

  • No. 1 Rx brand (annual absolute sales growth in rubles): Xarelto
  • No. 1 OTC brand (annual absolute sales growth in rubles): Polysorb
  • No. 1 Rx company (annual absolute sales growth in rubles): KRKA
  • No. 1 OTC company (annual absolute sales growth in rubles): Bionorica
  • No. 1 Rx launch (sales volume in rubles generated in the first 6 months of sales): Kostarox
  • No. 1 OTC launch (sales volume in rubles generated in the first 6 months of sales): Trimedat Forte

We congratulate the winners of all nominations and look forward to the results of the next year! 

RX Choice Award